These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 1399442

  • 1. Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy.
    Bonnerot V, Charpentier A, Frouin F, Kalifa C, Vanel D, Di Paola R.
    Invest Radiol; 1992 Oct; 27(10):847-55. PubMed ID: 1399442
    [Abstract] [Full Text] [Related]

  • 2. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
    van der Woude HJ, Bloem JL, Verstraete KL, Taminiau AH, Nooy MA, Hogendoorn PC.
    AJR Am J Roentgenol; 1995 Sep; 165(3):593-8. PubMed ID: 7645476
    [Abstract] [Full Text] [Related]

  • 3. Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping.
    Hanna SL, Parham DM, Fairclough DL, Meyer WH, Le AH, Fletcher BD.
    Invest Radiol; 1992 May; 27(5):367-73. PubMed ID: 1582820
    [Abstract] [Full Text] [Related]

  • 4. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M, Saueressig U, van Buiren M, Kontny U, Niemeyer C, Köhler G, Ilyasov K, Langer M.
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [Abstract] [Full Text] [Related]

  • 5. Dynamic contrast enhanced magnetic resonance imaging subtraction in evaluating osteosarcoma response to chemotherapy.
    Torricelli P, Montanari N, Spina V, Manfrini M, Bertoni F, Saguatti G, Romagnoli R.
    Radiol Med; 2001 Mar; 101(3):145-51. PubMed ID: 11402952
    [Abstract] [Full Text] [Related]

  • 6. [Osteosarcoma: magnetic resonance imaging of the effects of preoperative chemotherapy].
    Spina V, Torricelli P, Manfrini M, Picci P, Romagnoli R.
    Radiol Med; 1993 Jun; 85(6):725-32. PubMed ID: 8337428
    [Abstract] [Full Text] [Related]

  • 7. Automated pixel-by-pixel mapping of dynamic contrast-enhanced MR images for evaluation of osteosarcoma response to chemotherapy: preliminary results.
    Hanna SL, Reddick WE, Parham DM, Gronemeyer SA, Taylor JS, Fletcher BD.
    J Magn Reson Imaging; 1993 Jun; 3(6):849-53. PubMed ID: 8280973
    [Abstract] [Full Text] [Related]

  • 8. Role of dynamic MRI and clinical assessment in predicting histologic response to neoadjuvant chemotherapy in bone sarcomas.
    Amit P, Patro DK, Basu D, Elangovan S, Parathasarathy V.
    Am J Clin Oncol; 2014 Aug; 37(4):384-90. PubMed ID: 23388556
    [Abstract] [Full Text] [Related]

  • 9. Correlation of histopathology and multi-modal magnetic resonance imaging in childhood osteosarcoma: Predicting tumor response to chemotherapy.
    Teo KY, Daescu O, Cederberg K, Sengupta A, Leavey PJ.
    PLoS One; 2022 Aug; 17(2):e0259564. PubMed ID: 35157711
    [Abstract] [Full Text] [Related]

  • 10. Accuracy of MR imaging for estimating intraosseous extent of osteosarcoma.
    Onikul E, Fletcher BD, Parham DM, Chen G.
    AJR Am J Roentgenol; 1996 Nov; 167(5):1211-5. PubMed ID: 8911182
    [Abstract] [Full Text] [Related]

  • 11. Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma: comparison with (99m)Tc-MIBI scintigraphy.
    Wakabayashi H, Saito J, Taki J, Hashimoto N, Tsuchiya H, Gabata T, Kinuya S.
    Skeletal Radiol; 2016 Jan; 45(1):87-95. PubMed ID: 26385785
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.
    Cheon GJ, Kim MS, Lee JA, Lee SY, Cho WH, Song WS, Koh JS, Yoo JY, Oh DH, Shin DS, Jeon DG.
    J Nucl Med; 2009 Sep; 50(9):1435-40. PubMed ID: 19690035
    [Abstract] [Full Text] [Related]

  • 15. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
    Byun BH, Kong CB, Lim I, Choi CW, Song WS, Cho WH, Jeon DG, Koh JS, Lee SY, Lim SM.
    J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
    [Abstract] [Full Text] [Related]

  • 16. Factor analysis of medical image sequences in MR of head and neck tumors.
    Zagdanski AM, Sigal R, Bosq J, Bazin JP, Vanel D, Di Paola R.
    AJNR Am J Neuroradiol; 1994 Aug; 15(7):1359-68. PubMed ID: 7976950
    [Abstract] [Full Text] [Related]

  • 17. Treatment of high-grade bone sarcomas with neoadjuvant chemotherapy: the utility of sequential color Doppler sonography in predicting histopathologic response.
    van der Woude HJ, Bloem JL, van Oostayen JA, Nooy MA, Taminiau AH, Hermans J, Reynierse M, Hogendoorn PC.
    AJR Am J Roentgenol; 1995 Jul; 165(1):125-33. PubMed ID: 7785571
    [Abstract] [Full Text] [Related]

  • 18. Extremity osteosarcoma in childhood: prognostic value of radiologic imaging.
    Lawrence JA, Babyn PS, Chan HS, Thorner PS, Pron GE, Krajbich IJ.
    Radiology; 1993 Oct; 189(1):43-7. PubMed ID: 8372217
    [Abstract] [Full Text] [Related]

  • 19. Imaging assessment of osteosarcoma in childhood and adolescence: diagnosis, staging, and evaluating response to chemotherapy.
    Eftekhari F.
    Cancer Treat Res; 2009 Oct; 152():33-62. PubMed ID: 20213385
    [Abstract] [Full Text] [Related]

  • 20. Dynamic contrast-enhanced magnetic resonance imaging as a prognostic factor in predicting event-free and overall survival in pediatric patients with osteosarcoma.
    Guo J, Reddick WE, Glass JO, Ji Q, Billups CA, Wu J, Hoffer FA, Kaste SC, Jenkins JJ, Ortega Flores XC, Quintana J, Villarroel M, Daw NC.
    Cancer; 2012 Aug 01; 118(15):3776-85. PubMed ID: 22180392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.